Quantcast

Latest ALS Stories

2014-03-10 16:32:46

BALTIMORE, Md., March 10, 2014 /PRNewswire-USNewswire/ -- With the opening of the 14(th) Annual Robert Packard Center for ALS Research Symposium, the Packard Center and The ALS Association are pleased to announce the first scientific grant award from the Winokur Family Research Initiative. The inaugural grant will help to fund a project under the direction on Phil Wong, Ph.D., a Professor of Pathology at Johns Hopkins University and Liam Chen, M.D., Ph.D., Assistant Professor of...

2014-03-10 08:31:05

ROCKVILLE, Md., March 10, 2014 /PRNewswire/ -- Neuralstem, Inc. (NYSE MKT: CUR) today provided an update on its clinical trials program and reported its 2013 financial results for the year ended December 31, 2013. (Logo: http://photos.prnewswire.com/prnh/20061221/DCTH007LOGO) "2013 was an exciting year for advancement in our NSI-566 cell therapy clinical programs," said Karl Johe, PhD, Neuralstem's Chairman of the Board and Chief Scientific Officer. "Our Phase II ALS trial...

2014-03-04 14:06:51

New Keck School of Medicine of USC research finds vascular damage in mice with ALS contributes to early development of the neurodegenerative disease, while repairing damage delays disease progression Keck School of Medicine of USC neuroscientists have unlocked a piece of the puzzle in the fight against Lou Gehrig's disease, a debilitating neurological disorder that robs people of their motor skills. Their findings appear in the March 3, 2014, online edition of the Proceedings of the...

Canadian Study Discovers How Lou Gehrig's Disease Spreads
2014-02-19 08:57:05

Rebekah Eliason for redOrbit.com – Your Universe Online A new study from the University of British Columbia and Vancouver Coastal Health Research Institute has discovered how amyotrophic lateral sclerosis (ALS), commonly known as Lou Gehrig’s disease, spreads. This fatal neurodegenerative disease is transmitted from one cell to another, which provides hope that the disease can be blocked. ALS damages nerve cells located in the brain and the spinal cord. This causes the motor neurons...

2014-02-16 23:03:37

ALSFight.com Will Provide the Resources and Support Victims of ALS Need to Improve Their Health and Continue Living Meaningful Lives New York, NY (PRWEB) February 16, 2014 ALSFight.com, the ALS start up service dedicated to helping patients who suffer from ALS find ways to manage and treat their disease, is pleased to announce that they have launched a campaign on Indiegogo.com to help them raise funds to create and design their web and mobile application. Amyotrophic Lateral Sclerosis...

2014-02-13 12:27:28

More than 500 clubs throughout North America to hold a Group Fitness class on Feb. 22 in support of Augie's Quest, a non-profit searching for a cure for ALS IRVINE, Calif., Feb. 13, 2014 /PRNewswire/ -- In support of Augie's Quest, LA Fitness announced today that it will host an in-club Group Fitness( )class at more than 500 of the company's locations on February 22,( )2014. Augie's Quest is a nonprofit research initiative dedicated to finding treatments and a cure for...

2014-02-07 12:51:08

Study in human cells may improve ability to identify useful drug targets In most cases of amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, a toxin released by cells that normally nurture neurons in the brain and spinal cord can trigger loss of the nerve cells affected in the disease, Columbia researchers reported today in the online edition of the journal Neuron. The toxin is produced by star-shaped cells called astrocytes and kills nearby motor neurons. In ALS, the death...

2014-02-06 08:29:41

Live Webcast to Air on Tuesday, February 11, at 3:00 p.m. EST ROCKVILLE, Md., Feb. 6, 2014 /PRNewswire/ -- Neuralstem, Inc. (NYSE MKT: CUR) announced that President and CEO Richard Garr will present at the 16(th) Annual BIO CEO & Investor Conference 2014 in New York City on Tuesday, February 11, at 3:00 p.m. EST. Garr will present clinical updates on the company's 2014 NSI-566 cell therapy trials program, including ongoing ALS Phase II; ALS Phase II in Mexico City;...

2014-02-05 23:03:02

A study led by St. Jude Children’s Research Hospital offers a new avenue for scientists to pursue in the quest for desperately needed treatments for ALS Memphis, Tenn. (PRWEB) February 05, 2014 St. Jude Children’s Research Hospital scientists led a study showing that mutations in a gene responsible for amyotrophic lateral sclerosis (ALS) disrupt the RNA transport system in nerve cells. The findings appear in the current issue of the scientific journal Neuron and offer a new focus for...

2014-02-04 12:27:49

WASHINGTON, Feb. 4, 2014 /PRNewswire-USNewswire/ -- The ALS Association is pleased to announce the awarding of five new grants to investigate the causes and treatment of ALS. The ALS Association identified the focus of each of these grants as areas with high potential for progress. (Logo: http://photos.prnewswire.com/prnh/20131211/MM32178LOGO) ALS, which is also known as Lou Gehrig's Disease, is a progressive neurodegenerative disease that affects nerve cells in the brain and the...


Word of the Day
endocarp
  • The hard inner (usually woody) layer of the pericarp of some fruits (as peaches or plums or cherries or olives) that contains the seed.
This word comes from the Greek 'endon,' in, within, plus the Greek 'kardia,' heart.
Related